OCD Trial, Recruiting NCT06660225 Sponsor: Nader Pouratian Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT06660225
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with obsessive-compulsive disorder (OCD) according to standard medical guidelines (DSM-5)
  • People whose OCD is rated as severe, with a score of more than 27 on a recognised OCD severity scale (Yale-Brown Obsessive-Compulsive Scale)
  • People who have had severe OCD symptoms and significant life impairment for more than 5 years, despite trying both medication and psychological treatment
  • People who have tried at least two different medications that target serotonin (a brain chemical) and one additional supporting medication, without enough improvement
  • People who have tried an adequate course of cognitive behavioural therapy (a structured talking therapy) without enough improvement, as assessed by the study psychiatrist
  • People aged between 22 and 75
  • People who are able to understand and sign a written consent form agreeing to take part

Who may not be able to join:

  • People who have severe major depression that also includes psychotic features (such as hallucinations or delusions)
  • People assessed as having a significant risk of suicide, based on a specific rating scale score
  • People who also have a primary psychotic disorder, post-traumatic stress disorder (PTSD), or an eating disorder
  • People who have had a problem with substance or alcohol misuse or dependence in the past 12 months
  • People who show significant decline in memory or thinking ability, based on scores from two standard cognitive tests
  • People who have another significant neurological condition or illness affecting brain function (a tic disorder would not automatically exclude someone — confirm with trial site)
  • People whose pre-surgical brain scan (MRI) shows anything that the study neurosurgeon considers would make the surgical procedure unsafe
  • People who have any condition or health factor that would make the type of surgery involved in this trial unsafe (confirm specific details with trial site)
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nader Pouratian, M.D., Ph.D., University of Texas Southwestern Medical Center

Phone: 2146486630

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nader Pouratian
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 September 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Efficacy of amSTN stimulation on OCD symptoms as measured by YBOCS; Incidence of Adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov